Application 018716
- Type
- NDA
- Sponsor
- CNTY LINE PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TRANDATE | LABETALOL HYDROCHLORIDE | TABLET;ORAL | 100MG | Yes | No |
| 002 | TRANDATE | LABETALOL HYDROCHLORIDE | TABLET;ORAL | 200MG | Yes | No |
| 003 | TRANDATE | LABETALOL HYDROCHLORIDE | TABLET;ORAL | 300MG | Yes | No |
| 004 | TRANDATE | LABETALOL HYDROCHLORIDE | TABLET;ORAL | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N018716-001 | TRANDATE | LABETALOL HYDROCHLORIDE | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1985-05-24 | |
| N018716-002 | TRANDATE | LABETALOL HYDROCHLORIDE | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | |
| N018716-003 | TRANDATE | LABETALOL HYDROCHLORIDE | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | |
| N018716-004 | TRANDATE | LABETALOL HYDROCHLORIDE | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N018716-001 | TRANDATE | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1985-05-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N018716-002 | TRANDATE | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N018716-003 | TRANDATE | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N018716-004 | TRANDATE | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N018716-001 | TRANDATE | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1985-05-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N018716-002 | TRANDATE | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N018716-003 | TRANDATE | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N018716-004 | TRANDATE | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N018716-001 | TRANDATE | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1985-05-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N018716-002 | TRANDATE | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N018716-003 | TRANDATE | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N018716-004 | TRANDATE | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018716-001 | TRANDATE | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1985-05-24 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018716-002 | TRANDATE | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018716-003 | TRANDATE | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018716-004 | TRANDATE | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N018716-001 | TRANDATE | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1985-05-24 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N018716-002 | TRANDATE | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N018716-003 | TRANDATE | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N018716-004 | TRANDATE | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018716-001 | TRANDATE | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1985-05-24 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018716-002 | TRANDATE | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018716-003 | TRANDATE | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018716-004 | TRANDATE | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018716-001 | TRANDATE | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1985-05-24 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018716-002 | TRANDATE | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018716-003 | TRANDATE | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018716-004 | TRANDATE | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018716-001 | TRANDATE | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1985-05-24 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018716-002 | TRANDATE | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018716-003 | TRANDATE | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018716-004 | TRANDATE | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018716-001 | TRANDATE | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1985-05-24 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018716-002 | TRANDATE | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018716-003 | TRANDATE | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018716-004 | TRANDATE | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018716-001 | TRANDATE | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1985-05-24 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018716-002 | TRANDATE | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018716-003 | TRANDATE | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018716-004 | TRANDATE | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1984-08-01 | 5bbf6a4d5a75… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N018716-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N018716-003 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N018716-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N018716-003 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N018716-002 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N018716-003 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N018716-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N018716-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N018716-003 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N018716-002 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N018716-003 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N018716-002 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N018716-003 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N018716-001 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N018716-002 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N018716-003 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N018716-001 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N018716-002 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N018716-003 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N018716-001 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N018716-002 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N018716-003 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N018716-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N018716-002 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N018716-003 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N018716-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N018716-002 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N018716-003 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N018716-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N018716-002 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N018716-003 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N018716-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N018716-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N018716-003 | AB | 1 | ea99ee380514… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N018716-002 | AB | 1 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N018716-003 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N018716-002 | AB | 1 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N018716-003 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N018716-002 | AB | 1 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N018716-003 | AB | 1 | a67488948f0b… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Method Pharmaceuticals, LLC | 733d6e32-ac90-4796-bf25-9d5887c897a5 | 2025-12-23 | Warnings, Adverse reactions | LABETALOL HYDROCHLORIDE |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 99a715a0-4579-410c-b102-7ef6fab8db55 | 2025-12-19 | Warnings, Adverse reactions | LABETALOL HYDROCHLORIDE |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | Redpharm Drug | 32525ed4-3cca-2b99-e063-6294a90a6c66 | 2025-12-13 | Warnings, Adverse reactions | LABETALOL HYDROCHLORIDE |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Chartwell RX, LLC | ac439c08-1e47-4306-8308-b31d7a1a443c | 2025-12-02 | Warnings, Adverse reactions | LABETALOL HYDROCHLORIDE |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Mullan Pharmaceutical Inc. | fb5ef3ba-0a7e-4f41-9547-d734983da0d3 | 2025-12-01 | Warnings, Adverse reactions | LABETALOL HYDROCHLORIDE |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | e6836a01-220d-4b69-9b4a-c919daeb6ece | 2025-11-20 | Warnings, Adverse reactions | LABETALOL HYDROCHLORIDE |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Bryant Ranch Prepack | 0dcd514d-bda8-484b-8cf1-f5656aaab9ce | 2025-10-29 | Warnings, Adverse reactions | LABETALOL HYDROCHLORIDE |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Bryant Ranch Prepack | 20c26652-52da-4eef-8486-f91eb30e9ff7 | 2025-10-29 | Warnings, Adverse reactions | LABETALOL HYDROCHLORIDE |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Bryant Ranch Prepack | dafa7411-2857-4f5a-a587-4367cfbe2bfa | 2025-10-23 | Warnings, Adverse reactions | LABETALOL HYDROCHLORIDE |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | Amneal Pharmaceuticals LLC | dbf1e4c7-7c0c-4f2f-8cad-96bc6b800cfc | 2025-10-06 | Warnings, Adverse reactions | LABETALOL HYDROCHLORIDE |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Macleods Pharmaceuticals Limited | 366134cd-6244-45fc-99f1-0193a0221b3a | 2025-10-06 | Warnings, Adverse reactions | LABETALOL HYDROCHLORIDE |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | RedPharm Drug | 1e1b7355-4802-d277-e063-6394a90aef44 | 2025-07-29 | Warnings, Adverse reactions | LABETALOL HYDROCHLORIDE |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | NuCare Pharmaceuticals , Inc. | 3aff731f-1eec-19b5-e063-6294a90a3143 | 2025-07-28 | Warnings, Adverse reactions | LABETALOL HYDROCHLORIDE |
| Labetalol HCL | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | 312dde0d-5147-483e-968f-4e0d46114176 | 2025-06-19 | Warnings, Adverse reactions | LABETALOL HYDROCHLORIDE |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Caplin Steriles Limited | 77152699-1ca8-442a-8cb4-80b0ffbec6f2 | 2025-02-14 | Warnings, Adverse reactions | LABETALOL HYDROCHLORIDE |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | 5faacbcc-f88f-42f7-8702-791ee82c4d18 | 2025-01-09 | Warnings, Adverse reactions | LABETALOL HYDROCHLORIDE |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | American Health Packaging | 3004aa59-288c-4971-b77b-78789715ef5a | 2024-12-30 | Warnings, Adverse reactions | LABETALOL HYDROCHLORIDE |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Zydus Lifesciences Limited | a3c0cc1e-1c01-4009-afdc-d35a66546aec | 2024-11-30 | LABETALOL HYDROCHLORIDE | |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Bryant Ranch Prepack | 64cd636d-8b48-4f29-b41d-4a048335793e | 2024-11-20 | Warnings, Adverse reactions | LABETALOL HYDROCHLORIDE |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 5b059ef2-dec0-4cea-b8df-d87df3fea9e2 | 2024-09-06 | Warnings, Adverse reactions | LABETALOL HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 43199-037 | Labetalol Hydrochloride | labetalol hydrochloride | County Line Pharmaceuticals LLC | NDA | Current |
| 43199-038 | Labetalol Hydrochloride | labetalol hydrochloride | County Line Pharmaceuticals LLC | NDA | Current |
| 43199-039 | Labetalol Hydrochloride | labetalol hydrochloride | County Line Pharmaceuticals LLC | NDA | Current |
| 47781-552 | Labetalol Hydrochloride | labetalol hydrochloride | Alvogen Inc. | NDA | Current |
| 47781-552 | Labetalol Hydrochloride | labetalol hydrochloride | Alvogen Inc. | NDA | Current |
| 47781-552 | Labetalol Hydrochloride | labetalol hydrochloride | Alvogen Inc. | NDA | Current |
| 47781-552 | Labetalol Hydrochloride | labetalol hydrochloride | Alvogen Inc. | NDA | Current |
| 47781-552 | Labetalol Hydrochloride | labetalol hydrochloride | Alvogen Inc. | NDA | Current |
| 47781-553 | Labetalol Hydrochloride | labetalol hydrochloride | Alvogen Inc. | NDA | Current |
| 47781-553 | Labetalol Hydrochloride | labetalol hydrochloride | Alvogen Inc. | NDA | Current |
| 47781-553 | Labetalol Hydrochloride | labetalol hydrochloride | Alvogen Inc. | NDA | Current |
| 47781-553 | Labetalol Hydrochloride | labetalol hydrochloride | Alvogen Inc. | NDA | Current |
| 47781-553 | Labetalol Hydrochloride | labetalol hydrochloride | Alvogen Inc. | NDA | Current |
| 47781-554 | Labetalol Hydrochloride | labetalol hydrochloride | Alvogen Inc. | NDA | Current |
| 47781-554 | Labetalol Hydrochloride | labetalol hydrochloride | Alvogen Inc. | NDA | Current |
| 47781-554 | Labetalol Hydrochloride | labetalol hydrochloride | Alvogen Inc. | NDA | Current |
| 47781-554 | Labetalol Hydrochloride | labetalol hydrochloride | Alvogen Inc. | NDA | Current |
| 47781-554 | Labetalol Hydrochloride | labetalol hydrochloride | Alvogen Inc. | NDA | Current |
| 50090-2428 | Labetalol Hydrochloride | labetalol hydrochloride | A-S Medication Solutions | NDA | Current |
| 50090-3584 | Labetalol Hydrochloride | labetalol hydrochloride | A-S Medication Solutions | NDA | Current |
| 50090-4149 | Labetalol Hydrochloride | labetalol hydrochloride | A-S Medication Solutions | NDA | Current |
| 50090-4149 | Labetalol Hydrochloride | labetalol hydrochloride | A-S Medication Solutions | NDA | Current |
| 60760-231 | Labetalol Hydrochloride | labetalol hydrochloride | St. Mary's Medical Park Pharmacy | NDA | Current |
| 65483-391 | Trandate | labetalol hydrochloride | Prometheus Laboratories Inc. | NDA | Current |
| 65483-392 | Trandate | labetalol hydrochloride | Prometheus Laboratories Inc. | NDA | Current |
| 65483-393 | Trandate | labetalol hydrochloride | Prometheus Laboratories Inc. | NDA | Current |
| 68071-3180 | Labetalol Hydrochloride | labetalol hydrochloride | NuCare Pharmaceuticals, Inc. | NDA | Current |
| 70518-0027 | Labetalol Hydrochloride | labetalol hydrochloride | REMEDYREPACK INC. | NDA | Current |
| 70518-1887 | Labetalol Hydrochloride | labetalol hydrochloride | REMEDYREPACK INC. | NDA | Current |
| 70518-1887 | Labetalol Hydrochloride | labetalol hydrochloride | REMEDYREPACK INC. | NDA | Current |
| 71335-0118 | Labetalol Hydrochloride | labetalol hydrochloride | Bryant Ranch Prepack | NDA | Current |
| 71335-0118 | Labetalol Hydrochloride | labetalol hydrochloride | Bryant Ranch Prepack | NDA | Current |